Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Net loss	$ (567)	$ (33,904)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Amortization of deferred financing costs	1,768	13,929
Depreciation, amortization and accretion	27,597	6,071
Stock-based compensation expense	1,972	0
Change in fair value of interest rate swaps	4,638	(470)
Gain on previously held equity investment	0	(1,426)
Loss (gain) on the extinguishment of debt	(5,735)	1,219
Unrealized gains on foreign currency, net	21,239	0
Deferred tax (benefit) expense	(511)	450
Changes in assets and liabilities:
Accounts receivable	3,366	(5,927)
Prepaid expenses and other current assets	7,915	(9,934)
Accounts payable, accrued expenses, and other current liabilities	(9,584)	13,711
Due to/from SunEdison, net	(3,192)	23,120
Other noncurrent assets and liabilities	(2,838)	9,519
Net cash provided by operating activities	3,590	16,358
Cash flows from investing activities:
Capital expenditures	(47,105)	(94,475)
Change in cash committed for construction	0	20,493
Change in restricted cash	57,103	(55,854)
Cash paid for acquisitions, net of cash acquired	(32,128)	(113,851)
Deposits on investments	0	(860)
Cash acquired upon FERSA consolidation	8,022	0
Returns from BioTherm escrow and deposits	3,775	0
Net cash used in investing activities	(10,333)	(244,547)
Cash flows from financing activities:
Proceeds from Bridge Facility	0	400,000
Repayments on Bridge Facility	0	(91,469)
Repayments of the 2022 Senior Notes	(35,441)	0
Proceeds from system debt financing	0	48,800
Repayments of system debt financing	(29,477)	(98,041)
Net SunEdison investment	48,983	7,245
Dividends paid	(30,674)	0
Proceeds from private placement, net of fee	0	485,933
Proceeds from loans from parent and affiliates	0	5,111
Payment of deferred financing costs	0	(11,779)
Net cash (used in) provided by financing activities	(46,609)	745,800
Net (decrease) increase in cash and cash equivalents	(53,352)	517,611
Effect of exchange rate changes on cash and cash equivalents	1,528	(19)
Cash and cash equivalents at beginning of period	922,318	150,146
Cash and cash equivalents at end of period	$ 870,494	$ 667,738